| Literature DB >> 32964877 |
Gunasekaran Gopalakrishnan1, Raja Kalayarasan1, Senthil Gnanasekaran1, Biju Pottakkat1.
Abstract
BACKGROUND: Locally advanced long Siewert type II tumor requires total gastrectomy and D2 lymphadenectomy with distal esophagectomy and mediastinal lymphadenectomy for curative resection. In this scenario, a laparoscopic transhiatal approach is not feasible, and the conventional left thoracoabdominal approach is associated with increased morbidity. AIMS ANDEntities:
Keywords: Conduit; Siewert; gastrectomy; gastro-oesophageal junction; oesophagectomy
Year: 2021 PMID: 32964877 PMCID: PMC8083754 DOI: 10.4103/jmas.JMAS_99_20
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1(a) Schematic representation of long Siewert type II tumour. (b) Axial section of computed tomography of the abdomen showing long gastric involvement. (c) Coronal section of the same patient showing long oesophageal involvement
Figure 2(a) Port positions for laparoscopic total gastrectomy with D2 lymphadenectomy. (b) Dissection of station 7 lymph node (arrowhead) along the left gastric artery (arrow). (c) Umbilical tape tied around the lower oesophagus to provide traction during hiatal dissection. (d) Lower oesophagus transected using a laparoscopic linear cutter. (e) Completed D2 lymphadenectomy bed showing clipped right gastric artery (arrow) and left gastric artery (arrowhead). (f) Specimen of total gastrectomy with distal oesophagectomy
Figure 3(a) Assessment of vascular arcade using transillumination with bulldog clips applied over the second and third jejunal arteries to check adequate vascular flow based on the fourth jejunal artery. (b) Fourth jejunal artery-based long jejunal conduit. (c) Jejunal conduit is taken through the retrocolic route without a mesenteric twist. (d) Jejunal conduit placed in the mediastinum
Figure 4(a) Port positions for thoracoscopic distal oesophagectomy with subcarinal lymphadenectomy. (b) Subcarinal lymph nodes dissected (arrow) (c) Post-subcarinal lymphadenectomy (arrow) and oesophageal mobilisation to the level of the azygous vein. (d) Oesophagus transected below the level of the azygous vein. (e) Ryles' tube placed in the jejunum after completion of the posterior layer of oesophagojejunostomy. (f) Completed oesophagojejunostomy at the level of the azygous vein (arrow)
Clinicopathological features of patients who underwent oesophagogastrectomy with intrathoracic oesophagojejunostomy for locally advanced Siewert type II tumour
| Patient number | Age | Gender | Neoadjuvant chemotherapy regimen | Post-operative complications (Clavien–Dindo Grade II or more) | Pathological stage (ypTNM)* | Involved lymph node stations** |
|---|---|---|---|---|---|---|
| 1 | 48 | Male | CAPEOX# | Pneumonia | T3N2 | 110, 7 |
| 2 | 43 | Female | FLOT## | Nil | T3N1 | 107, 3 |
| 3 | 58 | Male | CAPEOX | Atrial fibrillation | T3N2 | 4d, 6, 9 |
#CAPEOX: Capecitabine + Oxaliplatin, ##FLOT: 5 fluorouracil + leucovorin + oxaliplatin + docetaxel, *AJCC Cancer Staging Manual (8th edition), **Lymph node stations as per the Japanese Classification of Oesophageal and Gastric Cancer